Cargando…
Pharmacokinetic-Pharmacodynamic modelling of intracellular Mycobacterium tuberculosis growth and kill rates is predictive of clinical treatment duration
Tuberculosis (TB) treatment is long and complex, typically involving a combination of drugs taken for 6 months. Improved drug regimens to shorten and simplify treatment are urgently required, however a major challenge to TB drug development is the lack of predictive pre-clinical tools. To address th...
Autores principales: | Aljayyoussi, Ghaith, Jenkins, Victoria A., Sharma, Raman, Ardrey, Alison, Donnellan, Samantha, Ward, Stephen A., Biagini, Giancarlo A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428680/ https://www.ncbi.nlm.nih.gov/pubmed/28356552 http://dx.doi.org/10.1038/s41598-017-00529-6 |
Ejemplares similares
-
Intracellular Pharmacodynamic Modeling Is Predictive of the Clinical Activity of Fluoroquinolones against Tuberculosis
por: Donnellan, Samantha, et al.
Publicado: (2019) -
Intracellular PD Modelling (PD(i)) for the Prediction of Clinical Activity of Increased Rifampicin Dosing
por: Aljayyoussi, Ghaith, et al.
Publicado: (2019) -
OptiMal-PK: an internet-based, user-friendly interface for the mathematical-based design of optimized anti-malarial treatment regimens
por: Aljayyoussi, Ghaith, et al.
Publicado: (2016) -
Remdesivir–ivermectin combination displays synergistic interaction with improved in vitro activity against SARS-CoV-2
por: Jeffreys, Laura N., et al.
Publicado: (2022) -
Treatment responses to Azithromycin and Ciprofloxacin in uncomplicated Salmonella Typhi infection: A comparison of Clinical and Microbiological Data from a Controlled Human Infection Model
por: Jin, Celina, et al.
Publicado: (2019)